PRLD vs. BWAY
PRLD (Prelude Therapeutics Incorporated) and BWAY (BrainsWay Ltd.) are both stocks. Both are in the Healthcare sector — PRLD in Biotechnology, BWAY in Medical Devices. Over the past 5 years, PRLD returned -32.17%/yr vs 27.73%/yr for BWAY. Their 0.13 correlation means their historical movements had little consistent relationship.
Performance
PRLD vs. BWAY - Performance Comparison
Loading charts...
Returns By Period
The year-to-date returns for both investments are quite close, with PRLD having a 58.62% return and BWAY slightly higher at 60.15%.
PRLD
- 1D
- -8.91%
- 1M
- -6.31%
- 6M
- 148.65%
- YTD
- 58.62%
- 1Y
- 455.35%
- 3Y*
- 7.62%
- 5Y*
- -32.17%
- 10Y*
- —
- ALL TIME*
- -25.26%
BWAY
- 1D
- -0.13%
- 1M
- 0.26%
- 6M
- 30.28%
- YTD
- 60.15%
- 1Y
- 165.56%
- 3Y*
- 135.57%
- 5Y*
- 27.73%
- 10Y*
- —
- ALL TIME*
- 14.81%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
BWAY BrainsWay Ltd. | $2.90M | $2.10M | $2.02M |
| $1.89M | $1.68M | $1.96M |
PRLD vs. BWAY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
PRLD Prelude Therapeutics Incorporated | 58.62% | 127.45% | -70.14% | -29.30% | -51.49% | -82.60% | 183.59% |
BWAY BrainsWay Ltd. | 60.15% | 101.70% | 45.52% | 162.35% | -67.92% | 2.12% | 33.93% |
Correlation
The correlation between PRLD and BWAY is 0.23, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.23 |
Correlation (3Y) Balances recent behavior with more history. | 0.18 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.16 |
Correlation (All Time) Calculated using the full available price history since Sep 25, 2020 | 0.13 |
The correlation between PRLD and BWAY shifts across timeframes, from 0.13 (all time) to 0.23 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
PRLD:
$261.89M
BWAY:
$597.37M
PRLD:
-$1.05
BWAY:
$0.34
PRLD:
20.32
BWAY:
7.05
PRLD:
6.31
BWAY:
3.83
PRLD:
$16.72M
BWAY:
$56.22M
PRLD:
$11.30M
BWAY:
$42.45M
PRLD:
-$82.17M
BWAY:
$12.57M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PRLD vs. BWAY — Risk / Return Rank
PRLD
BWAY
PRLD vs. BWAY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Prelude Therapeutics Incorporated (PRLD) and BrainsWay Ltd. (BWAY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PRLD | BWAY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.52 | ||
| Sortino ratioReturn per unit of downside risk | +0.21 | ||
| Omega ratioGain probability vs. loss probability | 1.53 | 1.42 | +0.11 |
| Calmar ratioReturn relative to maximum drawdown | 7.05 | 8.47 | -1.42 |
| Martin ratioReturn relative to average drawdown | 15.63 | 19.80 | -4.17 |
Loading charts...
Drawdowns
PRLD vs. BWAY - Drawdown Comparison
The maximum PRLD drawdown since its inception was -99.33%, which is greater than BWAY's maximum drawdown of -88.14%. Use the drawdown chart below to compare losses from any high point for PRLD and BWAY.
Loading charts...
Drawdown Indicators
| PRLD | BWAY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.33% | -88.14% | -11.19% |
Max Drawdown (1Y)Largest decline over 1 year | -70.10% | -19.10% | -51.00% |
Max Drawdown (3Y)Largest decline over 3 years | -90.42% | -36.33% | -54.09% |
Max Drawdown (5Y)Largest decline over 5 years | -98.42% | -83.71% | -14.71% |
Current DrawdownCurrent decline from peak | -94.98% | -11.30% | -83.68% |
Average DrawdownAverage peak-to-trough decline | -85.39% | -36.57% | -48.82% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 31.55% | 8.16% | +23.39% |
Volatility
PRLD vs. BWAY - Volatility Comparison
Prelude Therapeutics Incorporated (PRLD) has a higher volatility of 25.48% compared to BrainsWay Ltd. (BWAY) at 19.23%. This indicates that PRLD's price experiences larger fluctuations and is considered to be riskier than BWAY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PRLD | BWAY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 25.48% | 19.23% | +6.25% |
Volatility (6M)Calculated over the trailing 6-month period | 78.18% | 38.72% | +39.46% |
Volatility (1Y)Calculated over the trailing 1-year period | 199.86% | 54.07% | +145.79% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 125.59% | 62.70% | +62.89% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 121.41% | 61.36% | +60.05% |
Dividends
PRLD vs. BWAY - Dividend Comparison
Neither PRLD nor BWAY has paid dividends to shareholders.
Financials
PRLD vs. BWAY - Financials Comparison
This section allows you to compare key financial metrics between Prelude Therapeutics Incorporated and BrainsWay Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
PRLD and BWAY have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PRLD has higher volatility (25.48%) compared to BWAY (19.23%). In terms of maximum drawdown, PRLD dropped -99.33% vs BWAY's -88.14%.
BWAY currently has the higher Sharpe Ratio (2.99 vs 2.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PRLD and BWAY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer